.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Baxter
Colorcon
McKesson
Boehringer Ingelheim
Queensland Health
Express Scripts
Cantor Fitzgerald
Covington
Novartis

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,479,673

« Back to Dashboard

Details for Patent: 6,479,673

Title: Antiretroviral enantiomeric nucleotide analogs
Abstract:Resolved enantiomers of the formula ##STR1## wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.
Inventor(s): Holy; Antonin (Prague, CZ), Dvorakova; Hana (Prague, CZ), DeClercq; Erik Desire Alice (Lovenjoel, BE), Balzarini; Jan Marie Rene (Heverlee, BE)
Assignee: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (CZ) N/A (BE) Rega Stichting, V.Z.W. (N/A)
Filing Date:Feb 08, 2000
Application Number:09/500,148
Claims:1. A compound of the formula: ##STR13##

as the enriched or resolved (S) enantiomer.

2. A compound of the formula: ##STR14##

wherein LvO is a leaving group, as a racemate or as the enriched or resolved enantiomers.

3. The compound of claim 2 wherein Lv is toluenesulfonyl.

4. The compound of claim 2 which is the enriched or resolved (R) enantiomer.

5. The compound of claim 2 which is the enriched or resolved (S) enantiomer.

6. A compound of the formula: ##STR15##

as the enriched or resolved (R)enantiomer.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Johnson and Johnson
Merck
Dow
Queensland Health
Farmers Insurance
Cerilliant
AstraZeneca
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot